The study is taking place at the Center for Vaccinology (CEVAC) at Ghent University Hospital. OVX836 is a first-in-class influenza A vaccine candidate that targets the nucleoprotein (NP), a highly ...

Vaxart ( (VXRT) ) has released its Q3 earnings. Here is a breakdown of the information Vaxart presented to its investors. Vaxart, Inc. is a ...

As the pandemic went on and the vaccine came into play, wastewater testing started ... and mathematical perspective how they ...

Health Canada has authorized three influenza vaccines that could be used if bird flu became a pandemic, the agency says.

British Columbia’s Office of the Provincial Health recommended that people take preventative measures including staying up to ...

In addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines.

Protection from shots like the flu vaccine typically takes a couple of weeks to kick in, so getting one now may offer ...

Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective COVID-19 vaccines.

Our late-stage pipeline is comprised of our COVID-19 influenza combination and standalone influenza vaccine candidates. We ...

Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...